Researchers at Rice University and the University of Texas MD Anderson Cancer Center have refined and, for the first time, run in vivo tests of a method that may allow nanotube - based probes to locate
specific tumors in the body.
Rice University and MD Anderson researchers have developed a technique that uses fluorescent nanotube - based probes to locate
specific tumors in the body.
Your veterinarian will be able to explain how
the specific tumor in your animal is likely to respond to treatment and behave in the future.
Based on the specific diagnostic information that has been obtained for your pet, your veterinarian may be able to predict how
the specific tumor in your animal is likely to respond to treatment and behave in the future.
Not exact matches
Furthermore,
in cancer patients, the circulating DNA contains the genetic mutations which are
specific to the
tumor.
«To my great surprise, even injecting 10 million activated T cells
specific to the P1A antigen did not affect
tumor growth
in this induced
tumor model,» says Van den Eynde.
In the context of the collaboration between the Gates Center for Stem Cell Biology and the CU Cancer Center this was the second clinical trial we offered to our patients with the specific intent to eliminate the CSCs in their tumors.&raqu
In the context of the collaboration between the Gates Center for Stem Cell Biology and the CU Cancer Center this was the second clinical trial we offered to our patients with the
specific intent to eliminate the CSCs
in their tumors.&raqu
in their
tumors.»
Researchers used tissue and blood samples to show that the gammopathy (a precursor to myeloma)
in both mice and patients with Gaucher disease is triggered by
specific lipids, and that the antibodies made by
tumor cells
in nearly a third of myeloma patients are directed against such lipids.
«Shifting bacterial communities
in the stomach may influence cancer risk: Microbe changes linked with
specific conditions could explain differences
in risk and type of
tumor.»
«Just as normal cells with the same genome differentiate into many different cell types, a single
tumor characterized by
specific genetic mutations can contain many different types of cells — stem - like and more differentiated cells — with the difference being rooted
in their epigenetic information.
Prostate cancer risk groups are assigned based on the prostate biopsy results, which include the Gleason score (GS)-- an indication of how aggressively the
tumor cells may behave — and the prostate
specific antigen (PSA) level
in the patient's blood at the time of diagnosis.
But
in May, the U.S. Food and Drug Administration for the first time allowed the use of an existing approved drug, Keytruda, to treat any solid
tumor bearing a
specific genetic marker.
«When most people think about cancer genetics, they think about single key mutations that foster
tumor formation — very
specific things like the BRCA genes,» said Joe R. Delaney, PhD, a fellow
in the Clinical Translation program at UC San Diego Moores Cancer Center and lead author of the paper published February 15
in Nature Communications.
Published
in the February 27 issue of Cell, the study found that
tumor cells that reach the brain — and successfully grow into new
tumors — hug capillaries and express
specific proteins that overcome the brain's natural defense against metastatic invasion.
«If we could load these virus shells with a different cargo, say a drug, and target it to a particular place
in the body, such as a
tumor, it could then deliver the drug to just that
specific location, making the drug more effective, or reducing side effects,» Lawrence said.
The scientists have shown that,
in all cancers, a sort of «identity crisis» is observed
in cancerous cells:
in the organs or tissues
in which a
tumor develops, genes
specific to other tissues or to other stages of the development of the organism express themselves
in an aberrant manner.
Most cancer vaccines developed to date have been designed to recognize and attack a
specific known molecule — such as a cell - surface receptor — that is likely to be found on cancerous cells
in any patient with that type of
tumor.
By focusing on these genes that are «awakened»
in tumors, the researchers have shown that
in almost all cancers, tens of
specific genes
in the germline and the placenta are aberrantly activated.
In principle, an attack by such T - cells on
tumors should be particularly powerful as well as highly
tumor -
specific and thus sparing of healthy cells.
The opposing functions of TAMs
in the development of
tumors arise the question whether there are
specific factors within the micro-environment of the
tumor which dictate the phenotype of these TAMs.
Scientists now know that what matters most
in determining the behavior of a particular cancer (and its response to
specific therapy) are the molecular pathways that drive malignant cell growth instead of where the
tumor begins
in the body.
Indeed,
tumors contain a lot of
specific macrophages that play a decisive role
in the formation of blood vessels.
The new test uses a highly sensitive gene mutation detection method that is based on the partitioning of DNA into droplets to detect
specific circulating
tumor DNA mutations and RNA variants
in whole blood.
A total of 67 biochemical features discriminated cancer from benign
tumors in these samples, but only four
specific metabolites could be considered as biomarkers for cancer: creatinine riboside, tryptophan, Nε, Nε, Nε - trimethyllysine, and 3 - methylhistidine.
In earlier studies involving animal models and human cancer cell lines, researchers found that breast cancer spreads when three specific cells are in direct contact: an endothelial cell (a type of cell that lines the blood vessels), a perivascular macrophage (a type of immune cell found near blood vessels), and a tumor cell that produces high levels of Mena, a protein that enhances a cancer cell's ability to sprea
In earlier studies involving animal models and human cancer cell lines, researchers found that breast cancer spreads when three
specific cells are
in direct contact: an endothelial cell (a type of cell that lines the blood vessels), a perivascular macrophage (a type of immune cell found near blood vessels), and a tumor cell that produces high levels of Mena, a protein that enhances a cancer cell's ability to sprea
in direct contact: an endothelial cell (a type of cell that lines the blood vessels), a perivascular macrophage (a type of immune cell found near blood vessels), and a
tumor cell that produces high levels of Mena, a protein that enhances a cancer cell's ability to spread.
The title of the paper is «Bioinformatic analysis reveals a pattern of STAT3 - associated gene expression
specific to basal - like breast cancers
in human
tumors.»
In NSCLC there are
specific genetic abnormalities within the
tumor that can be exploited with drugs
specific for the molecular abnormality.
Hoping to cash
in on personalized cancer therapy, a new company called Foundation Medicine — founded
in part by genome guru Eric Lander of the Broad Institute — plans to develop tests for genetic glitches
in tumors that make them vulnerable to
specific drugs, reports the United Kingdom's Times Online.
However, it was unclear at this stage
in their research if this was a species -
specific finding limited to animal
tumor models or if this was a biologic phenomenon that may also be present
in cancer patients.
«The finding that certain cell signaling lipids change the activity of an oncogenic Ras protein, suggests that we might be able to interfere with
tumor progression by inhibiting the enzymes which make the
specific cell signaling lipid
in cells,» Buck said.
«This study provided a conceptual framework for the discovery of «traceable» targets
in cancers harboring
specific tumor suppressor deficiencies.»
Approximately 80 percent of DIPG
tumors have a
specific mutation
in a histone gene.
«Identifying targets essential to cell survival
in tumor suppressor genes has long been an investigational goal with the aim of offering cancer -
specific vulnerabilities for targeted therapy,» said Ronald DePinho, M.D., professor of Cancer Biology, MD Anderson president, and senior author for the Nature paper.
Scientists identified the
specific proteins secreted by the parasite Toxoplasma gondii that cause the immune system
in mice to attack established ovarian
tumors.
«We searched for genes that are occasionally deleted
in some cancers but which are retained
in cancers caused by
specific tumor suppressing genes, such as PTEN,» said Di Zhao, Ph.D., Odyssey postdoctoral fellow
in Cancer Biology and first author on the Nature paper.
A new method has been found for identifying therapeutic targets
in cancers lacking
specific key
tumor suppressor genes.
She is investigating the role of glycosylated molecules
in tumor progression and metastasis, tissue - and species -
specific expression of lectin receptors that play a role
in regulating host innate immune responses and inflammation, and the immunological mechanisms underlying chronic inflammation and cancer development.
They found that the levels of two
specific tRNAs were significantly higher
in metastatic cells and metastatic
tumors than
in primary
tumors that did not metastasize or healthy samples.
A relatively new biomarker called prostate -
specific membrane antigen (PSMA) is the bullseye for three new magnetic resonance imaging (MRI) agents that bind to the protein
in not only prostate cancer, but a range of
tumor types, according to research unveiled at the 2015 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).
«Knowing the mutations that are driving a
tumor over time could help us predict the genetic course of the disease, so that we can intervene
in a more
specific fashion,» said the studies» senior author Dr. C. Ryan Miller, a member of UNC Lineberger and associate professor
in the UNC School of Medicine.
For example, drugs that target a
specific BRAF gene mutation commonly found
in melanoma shrink
tumors in about half of patients with the mutation.
For example, the shells could be functionalized to fluoresce
in the presence of
specific proteins or to target
tumors.
One approach is to give patients
specific antibodies that target the homing devices (essentially chemical receptors)
in white blood cells, rendering the
tumor cells immunologically visible.
Dr. Gnjatic's research focuses on human antigen -
specific immune responses to
tumor antigens,
in an attempt to define new targets for the development of cancer immunotherapies, assess the efficacy of these immunotherapies, and learn why they may fail.
About half of melanoma patients harbor an identical
tumor -
specific mutation
in the BRAF gene, which encodes a protein kinase that helps drive cell growth.
Monje's team identified a
specific protein, called neuroligin - 3, which is largely responsible for the increase
in tumor growth associated with neuronal activity
in the cerebral cortex.
Over the past two years, investigators from the Perelman School of Medicine at the University of Pennsylvania have reported results from a human trial
in GBM using chimeric antigen receptor (CAR) T cell therapy, through which patients» own T cells were engineered to track down and kill cancer cells that express a
tumor -
specific protein known as EGFRvIII.
The software allowed them to cluster genes into groups associated with
specific molecular processes and see which processes
in tumors and blood cells were associated with each other.
Testosterone treatment alone did not induce
specific tumors at other sites, but compared with control rats, it caused a significant increase
in the number of rats with malignant
tumors at any site.
A newly devised
tumor -
specific fluorescent agent and imaging system guided surgeons
in real time to remove additional
tumors in ovarian cancer patients that were not visible without fluorescence or could not be felt during surgery, reports Alexander L. Vahrmeijer MD, PhD, head of the Image - guided Surgery group
in the Department of Surgery at Leiden University Medical Center
in the Netherlands.